tradingkey.logo
tradingkey.logo
Search

FDA Removes Partial Clinical Hold On Macrogenics’ Linnet Study

ReutersApr 8, 2026 8:38 PM

- MacroGenics Inc MGNX.O:

  • FDA REMOVES PARTIAL CLINICAL HOLD ON MACROGENICS’ LINNET STUDY

  • MACROGENICS INC - NEW PARTICIPANTS TO BE ENROLLED UNDER REVISED PROTOCOL WITH ADDITIONAL RISK-MITIGATION MEASURES

  • MACROGENICS INC: WE REMAIN ON TRACK TO PROVIDE A MID-YEAR CLINICAL UPDATE ON PROGRAM

  • MACROGENICS INC - PLAN TO RESUME ENROLLMENT IN CLINICAL STUDY OF LORIGERLIMAB IN GYNECOLOGIC CANCERS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI